Real World Outcomes With Chemotherapy and Immunotherapy in Metastatic Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinomas

ABSTRACT Background Gastroenteropancreatic poorly differentiated neuroendocrine carcinomas (GEP‐NECs) are aggressive cancers where cytotoxic chemotherapy is the backbone of treatment. While the addition of immunotherapy with immune checkpoint inhibitors (IOs) to chemotherapy is recommended for lung...

Повний опис

Бібліографічні деталі

Автори:	Rushabh Gujarathi, Samantha Kwock, Faith Abodunrin, Namrata Setia, Xavier M. Keutgen, Chih‐Yi Liao
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Wiley 2026-04-01
Серія:	Cancer Medicine
Предмети:	chemotherapy immunotherapy ncdb neuroendocrine carcinomas neuroendocrine tumors
Онлайн доступ:	https://doi.org/10.1002/cam4.71809
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!